FDA Clearance Tracker · P030022-S039
REFLECTION CERAMIC ACETABULAR HIP SYSTEM (RCHS)
Last checked: Nov 20, 2026Latest source record: Mar 20, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 20, 2018
Approved
Time to decision
547 days
Received Sep 19, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030022-S039
- Device name
- REFLECTION CERAMIC ACETABULAR HIP SYSTEM (RCHS)
- Applicant
- Smith & Nephew, Inc.
- Applicant location
- Memphis, TN
- Received
- Sep 19, 2016
- Decided
- Mar 20, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P030022
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the updated physician and patient labeling based on post approval study data.
Source documents
Other decisions for Smith & Nephew, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Tendon Anchor510(k)
K263461 · Decided Oct 27, 2026 · 29 days after receipt
Device type: Staple, Implantable (GDW) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.